Bristol-Myers exec charged with insider trading
Associated Press//August 2, 2012//
NEWARK, N.J. — A Bristol-Myers Squibb executive has been charged with insider trading.
The U.S. attorney’s office in Newark, N.J., says Robert Ramnarine bought and sold stock in companies that his pharmaceutical firm was considering buying.
As director and later executive director of pension and savings investments, Ramnarine was assigned to check out the pension plans of firms under consideration for purchase.
Authorities say his illegal trades made him about $310,000 in profits from 2010 through this year.
He is due in federal court in Newark later Thursday.
Related Content
Editors Picks
Learn about the 2026 Leaders in Law honorees
21/4/2026
Contractor, MD consultant charged in alleged USPS bribery conspiracy
20/4/2026
Lawyer didn’t commit ‘obvious error’ on cell tower testimony, [...]
20/4/2026
MD colleges start programs to give high schoolers jump on campus life
20/4/2026
Judge: Baltimore IG’s records access ‘crushed’ by administrati[...]
17/4/2026
More News
Judge blocks Trump administration actions stymieing wind, solar projects
21/4/2026
Chavez-DeRemer steps down as US labor secretary amid misconduct probe
21/4/2026
Federal judge blocks $6B Nexstar-Tegna TV merger
21/4/2026
Supreme Court rejects Massachusetts school gender-identity policy challenge
20/4/2026
Trump ballroom construction allowed for now, appeals court says
20/4/2026











